Schedule 13G ownership disclosure
Sunesis Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 867328700
Event date: 2017-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,265,455
- Percent of class
- 6.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001580642-18-000852
- Form type
- SC 13G
- Filer
- EVENTIDE ASSET MANAGEMENT, LLC
- CIK
- CIK 1442891
- Filed
- Feb 12, 2018
- Reporting period
- Dec 31, 2017
- Description
- Schedule 13G beneficial ownership